Having access to both medications through a single provider gives you flexibility to switch if semaglutide alone does not produce adequate results
The tradeoff is that excessive slowingespecially from medicationscan cause nausea in some patients
This is exactly the kind of decision that should be made with a provider not based on a social media recommendation or a friend's experience
A member of our team has even personally undergone peptide therapy, enabling us to provide information about the patient experience that can only be gained from hands-on experience
"Our study highlights several biological pathways by which GLP1 drugs may influence Alzheimer's, including reducing inflammation, improving insulin signaling in the brain, and altering enzymes involved in the production of amyloidbeta." GLP-1 drugs get their name from the glucagon-like peptide-1 (GLP-1) hormone that they mimic
For patients who already have a primary care doctor running regular labs, this may feel redundant